DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Bachelot T, Bourgier C, Cropet C et al.
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.
J Clin Oncol 2012;
30: 2718-2724
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.